Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)

Heijde, D. van der; Gladman, D.D.; Kishimoto, M.; Okada, M.; Rathmann, S.S.; Moriarty, S.R.; ... ; Mease, P.J. (2018)

Article / Letter to editor

• BIOLOGIC DMARD
• PSORIATIC ARTHRITIS
• SPONDYLOARTHRITIS
• TREATMENT

• All authors: Heijde, D. van der; Gladman, D.D.; Kishimoto, M.; Okada, M.; Rathmann, S.S.; Moriarty, S.R.; Shuler, C.L.; Carlier, H.; Benichou, O.; Mease, P.J.
• Date: 2018-03-01
• Journal: The Journal of Rheumatology
• Volume: 45
• Issue: 3
• Pages: 367 - 377
• DOI: doi:10.3899/jrheum.170429
• Link: http://www.jrheum.org/content/45/3/367